Testing effectiveness (Phase 2)Ended earlyNCT00126568
What this trial is testing
Sorafenib in Treating Patients With Advanced Anaplastic Thyroid Cancer
Who this might be right for
Anaplastic Thyroid CancerRecurrent Thyroid Cancer
National Cancer Institute (NCI) 20